Shinichiro Kashiwagi1, Yuka Asano2, Wataru Goto2, Tamami Morisaki2, Masatsune Shibutani3, Hiroaki Tanaka3, Kosei Hirakawa2,3, Masaichi Ohira2,3. 1. Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan; kashiwa@med.osaka-cu.ac.jp. 2. Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan. 3. Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Abstract
BACKGROUND/AIM: Augmented reality (AR) is a new technology that provides new awareness by using a computer to extend the real environment perceived by humans. Optical see-through head-mounted displays (OST-HMD) are worn on the head and can faithfully generate an AR image by wearing the device on the head as a spectacle-type device. We developed an ultrasound-guided needle biopsy technique using OST-HMD for breast tumors. PATIENTS AND METHODS: Moverio BT-35E (Seiko Epson Corp, Nagano, Japan) was used as the OST-HMD device. This technique involves performing needle biopsy under direct vision via the gap at the bottom of the display while the ultrasound images are projected on the display of the OST-HMD worn on the head. RESULTS: With this technique, needle biopsy can be executed smoothly with no posture restrictions. A flip shade affixed to the OST-HMD has 2% transmittance, which enables clearer projection of the images. CONCLUSION: This article outlines the ultrasound-guided needle biopsy using OST-HMD. We established a safe and accurate biopsy technique with technological innovations using AR. Copyright
BACKGROUND/AIM: Augmented reality (AR) is a new technology that provides new awareness by using a computer to extend the real environment perceived by humans. Optical see-through head-mounted displays (OST-HMD) are worn on the head and can faithfully generate an AR image by wearing the device on the head as a spectacle-type device. We developed an ultrasound-guided needle biopsy technique using OST-HMD for breast tumors. PATIENTS AND METHODS: Moverio BT-35E (Seiko Epson Corp, Nagano, Japan) was used as the OST-HMD device. This technique involves performing needle biopsy under direct vision via the gap at the bottom of the display while the ultrasound images are projected on the display of the OST-HMD worn on the head. RESULTS: With this technique, needle biopsy can be executed smoothly with no posture restrictions. A flip shade affixed to the OST-HMD has 2% transmittance, which enables clearer projection of the images. CONCLUSION: This article outlines the ultrasound-guided needle biopsy using OST-HMD. We established a safe and accurate biopsy technique with technological innovations using AR. Copyright
Authors: Dalia M Abd El-Rehim; Graham Ball; Sarah E Pinder; Emad Rakha; Claire Paish; John F R Robertson; Douglas Macmillan; Roger W Blamey; Ian O Ellis Journal: Int J Cancer Date: 2005-09-01 Impact factor: 7.396
Authors: Long Qian; Alexander Barthel; Alex Johnson; Greg Osgood; Peter Kazanzides; Nassir Navab; Bernhard Fuerst Journal: Int J Comput Assist Radiol Surg Date: 2017-03-25 Impact factor: 2.924
Authors: Rafa Rahman; Matthew E Wood; Long Qian; Carrie L Price; Alex A Johnson; Greg M Osgood Journal: Surg Innov Date: 2019-09-12 Impact factor: 2.058
Authors: Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein Journal: Proc Natl Acad Sci U S A Date: 2003-06-26 Impact factor: 12.779